On November 11, Aehr Test rose 10.86% in Regular Trading, trading near $65.9419/share, with turnover of $17.1942 million.
The move was accompanied by continued market focus on the company’s better-than-expected fiscal first-quarter results, higher full-year revenue outlook, and ongoing progress in AI chip testing equipment orders and deployments.
Reported results showed adjusted EPS of $0.28 versus market expectations of $0.11, while revenue reached $33.007 million versus expectations of $27.072 million. The company also disclosed backlog of $100.9 million as of September 25. In addition, it has been advancing deployments tied to a major AI accelerator customer, including a fully configured FOX-XP wafer-level burn-in test system planned for installation at a partner facility in Taiwan in early 2027, while a previously announced follow-on AI chip testing equipment order was about $6 million. These disclosed factors provide a clear basis for the stock’s strength.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments